Statement Of Comprehensive Income [Abstract]

OSE Immunotherapeutics - Filing #880997

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of comprehensive income [abstract]
Profit (loss)
16 850 EUR
16 850 EUR
16 555 EUR
16 555 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans
25,000 EUR
25,000 EUR
3,000 EUR
3,000 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
55,000 EUR
55,000 EUR
4,000 EUR
4,000 EUR
Other comprehensive income
29,000 EUR
7,000 EUR
Comprehensive income
16 825 EUR
0 EUR
0 EUR
0 EUR
55,000 EUR
16 879 EUR
0 EUR
16 561 EUR
4,000 EUR
0 EUR
0 EUR
16 558 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.